Personal information

Emails & domains

Verified email addresses

Verified email domains

Countries

Australia

Activities

Collapse all

Funding (8)

Identifying biomarkers of response to chemo-immunotherapy in mesothelioma

2021 to 2023 | Grant
NSW icare Dust Diseases Care (NSW, NSW, AU)
Source: Self-asserted source
Alison McDonnell

Laboratory tests to understand why some patients with mesothelioma respond better to a combination of chemotherapy and immunotherapy

2019 to 2019 | Grant
Cancer Council Western Australia (WA, WA, AU)
Source: Self-asserted source
Alison McDonnell

Identifying immune biomarkers of response to chemotherapy in malignant mesothelioma

2018-05 to 2020-04 | Grant
NSW icare Dust Diseases Care (Sydney, New South Wales, AU)
Source: Self-asserted source
Alison McDonnell

Identifying immune biomarkers of response to chemotherapy in thoracic cancers

2016 to 2017 | Salary award
Raine Medical Research Foundation (WA, WA, AU)
Source: Self-asserted source
Alison McDonnell

Tracking the T cell repertoire at the tumour site in mesothelioma and lung cancer

2016 to 2016 | Contract
Cancer Council Western Australia (WA, WA, AU)
Source: Self-asserted source
Alison McDonnell

Malignant Pleural Effusion: tracking anti-tumour immunity at the effector site

2013 to 2013 | Grant
Cancer Council Western Australia (WA, WA, AU)
Source: Self-asserted source
Alison McDonnell

The role of dendritic cells in the cross-presentation of tumour antigen

2005 to 2008 | Award
National Health and Medical Research Council (ACT, ACT, AU)
Source: Self-asserted source
Alison McDonnell

The role of dendritic cells in the cross-presentation of tumour antigen

2005 to 2005 | Grant
Australian Lung Foundation (QLD, QLD, AU)
Source: Self-asserted source
Alison McDonnell
How many people are using ORCID?